5 Micro-Cap Healthcare Stocks Insiders Are Buying

2. Surrozen Inc (NASDAQ:SRZN)

Number of Hedge Fund Investors: 12

Surrozen Inc (NASDAQ:SRZN) is working on treatments for tissue injury by using targeted regenerative antibodies. Tim Kutzkey, a director and 10% owner at Surrozen Inc (NASDAQ:SRZN), bought 193,548 shares at $15.50 per share on April 4. Since then the stock has lost about 9% in value.

As of the end of the last quarter of 2023, 12 hedge funds tracked by Insider Monkey had stakes in Surrozen Inc (NASDAQ:SRZN). Jim Simons’s Euclidean Capital owns a $824,342 stake in Surrozen Inc (NASDAQ:SRZN).